Want to see GB:WWH full AI Analyst Report?
WWH Stock Chart & Stats
384.50 p
2.00 p(0.52%)
At close: 4:00 PM EDT
384.50 p
2.00 p(0.52%)
Day’s Range― - ―
52-Week Range320.00 p - 401.50 p
Previous CloseN/A
Volume71.61K
Average Volume (3M)1.52M
Market Cap
£1.42B
Enterprise Value1.22B
Total Cash (Recent Filing)£70.82M
Total Debt (Recent Filing)£18.88M
Price to Earnings (P/E)14.6
Beta0.82
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.61%
Share Statistics
EPS (TTM)0.27
Shares Outstanding358,788,570
10 Day Avg. Volume1,353,432
30 Day Avg. Volume1,519,410
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)1.02
Price to Sales (P/S)113.12
P/FCF Ratio-1.83K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Global Healthcare PortfolioExposure across geographies and healthcare subsectors can reduce dependence on any single company, drug, market or technology. This breadth supports a more resilient long-term portfolio structure while retaining access to both mature healthcare businesses and innovation-led opportunities.
Conservatively Positioned Balance SheetVery low leverage and a large equity base provide a substantial financial cushion, limiting balance-sheet strain during periods of portfolio volatility. Declining absolute debt also supports financial flexibility and reduces the risk that financing obligations impair shareholder returns.
Specialist Healthcare Investment MandateA focused healthcare mandate gives the manager a defined opportunity set spanning pharmaceuticals, biotechnology, devices and services. The specialist structure can support consistent research depth and portfolio positioning across multiple healthcare business models over a multi-year horizon.
Bears Say
Weak And Inconsistent Cash GenerationRepeated negative or negligible cash generation weakens confidence in the quality of reported profits and limits internally generated financial resources. It also indicates returns may rely heavily on portfolio revaluations, non-cash gains or other movements rather than recurring cash conversion.
Highly Volatile Earnings And ProfitabilitySharp year-to-year changes in revenue and net income make the trust’s performance difficult to forecast and reduce confidence in durable profitability. The combination of losses in some periods and negative gross profit in 2026 suggests reported earnings may remain sensitive to portfolio market movements.
Exposure To Healthcare Investment RisksThe portfolio remains exposed to binary clinical results, regulatory decisions, foreign-exchange movements and manager execution. These risks can materially affect underlying holdings and NAV across several months, even when the trust’s diversified structure limits single-company concentration.
Worldwide Healthcare Trust PLC GBP News
WWH FAQ
What was Worldwide Healthcare Trust PLC GBP’s price range in the past 12 months?
Worldwide Healthcare Trust PLC GBP lowest share price was 320.00 p and its highest was 401.50 p in the past 12 months.
What is Worldwide Healthcare Trust PLC GBP’s market cap?
Worldwide Healthcare Trust PLC GBP’s market cap is £1.42B.
When is Worldwide Healthcare Trust PLC GBP’s upcoming earnings report date?
Worldwide Healthcare Trust PLC GBP’s upcoming earnings report date is Nov 18, 2026 which is in 82 days.
How were Worldwide Healthcare Trust PLC GBP’s earnings last quarter?
Worldwide Healthcare Trust PLC GBP released its earnings results on Jun 05, 2026. The company reported 0.165 p earnings per share for the quarter, beating the consensus estimate of N/A by 0.165 p.
Is Worldwide Healthcare Trust PLC GBP overvalued?
According to Wall Street analysts Worldwide Healthcare Trust PLC GBP’s price is currently Overvalued.
Does Worldwide Healthcare Trust PLC GBP pay dividends?
Worldwide Healthcare Trust PLC GBP pays a Semiannually dividend of 1.7 p which represents an annual dividend yield of 0.61%. See more information on Worldwide Healthcare Trust PLC GBP dividends here
What is Worldwide Healthcare Trust PLC GBP’s EPS estimate?
Worldwide Healthcare Trust PLC GBP’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Worldwide Healthcare Trust PLC GBP have?
Worldwide Healthcare Trust PLC GBP has 358,788,570 shares outstanding.
What happened to Worldwide Healthcare Trust PLC GBP’s price movement after its last earnings report?
Worldwide Healthcare Trust PLC GBP reported an EPS of 0.165 p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.023%.
Which hedge fund is a major shareholder of Worldwide Healthcare Trust PLC GBP?
Currently, no hedge funds are holding shares in GB:WWH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Worldwide Healthcare Trust PLC GBP
Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap companies with a market capitalization of at least $5 billion. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Healthcare Index. The fund employs internal research to make its investments. It was formerly known as Finsbury Worldwide Pharmaceutical Trust plc. Worldwide Healthcare Trust PLC was formed in April 1995 and is domiciled in the United Kingdom.